- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metabolic modeling-based drug repurposing in Glioblastoma ; volume:12 ; number:1 ; day:1 ; month:7 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (1.7.2022), 1-13, 12.2022
- Urheber
-
Tomi-Andrino, Claudio
Pandele, Alina
Winzer, Klaus
King, John
Rahman, Ruman
Kim, Dong-Hyun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-14721-w
- URN
-
urn:nbn:de:101:1-2022082122272283981126
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tomi-Andrino, Claudio
- Pandele, Alina
- Winzer, Klaus
- King, John
- Rahman, Ruman
- Kim, Dong-Hyun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement
Repurposing of approved cardiovascular drugs
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement
Repurposing of approved cardiovascular drugs
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement